Surgical Outcomes Research Centre (SOuRCe), Centre for Perioperative Medicine, Division of Surgical and Interventional Science, University College London, London, UK; Department of Anaesthesia and Perioperative Medicine, University College London Hospitals, London, UK.
Surgical Outcomes Research Centre (SOuRCe), Centre for Perioperative Medicine, Division of Surgical and Interventional Science, University College London, London, UK; Department of Anaesthesia and Perioperative Medicine, University College London Hospitals, London, UK.
Br J Anaesth. 2022 Mar;128(3):449-456. doi: 10.1016/j.bja.2021.12.006. Epub 2022 Jan 7.
Days alive and out of hospital (DAOH) is a composite, patient-centred outcome measure describing a patient's postoperative recovery, encompassing hospitalisation and mortality. DAOH is the number of days not in hospital over a defined postoperative period; patients who die have DAOH of zero. The Standardising Endpoints in Perioperative Medicine (StEP) group recommended DAOH as a perioperative outcome. However, DAOH has never been validated in patients undergoing emergency laparotomy. Here, we validate DAOH after emergency laparotomy and establish the optimal duration of observation.
Prospectively collected data of patients having emergency laparotomy in England (December 1, 2013-November 30, 2017) were linked to national hospital admission and mortality records for the year after surgery. We evaluated construct validity by assessing DAOH variation with known perioperative risk factors and predictive validity for 1 yr mortality using a multivariate Bayesian mixed-effects logistic regression. The optimal postoperative DAOH period (30 or 90 days) was judged on distributional and pragmatic properties.
We analysed 78 921 records. The median 30-day DAOH (DAOH) was 16 (inter-quartile range [IQR], 0-22) days and the median DAOH was 75 (46-82) days. DAOH was shorter in the presence of known perioperative risk factors. For patients surviving the first 30 postoperative days, shorter DAOH was associated with higher 1-yr mortality (odds ratio=0.94; 95% credible interval, 0.94-0.94).
DAOH is a valid, patient-centred outcome after emergency laparotomy. We recommend its use in clinical trials, quality assurance, and quality improvement, measured at 30 days as mortality heavily skews DAOH measured at 90 days and beyond.
存活且出院天数(DAOH)是一种综合的、以患者为中心的术后恢复结果衡量指标,包含住院时间和死亡率。DAOH 是指在特定术后时间段内未住院的天数;死亡患者的 DAOH 为 0。标准化围手术期终点(StEP)小组推荐 DAOH 作为围手术期的结果。然而,DAOH 从未在接受急诊剖腹手术的患者中得到验证。在此,我们验证了急诊剖腹手术后的 DAOH,并确定了最佳观察时间。
前瞻性收集英格兰接受急诊剖腹手术的患者数据(2013 年 12 月 1 日至 2017 年 11 月 30 日),并与术后一年内国家住院和死亡率记录相关联。我们通过评估 DAOH 与已知围手术期危险因素的变化来评估结构有效性,并使用多元贝叶斯混合效应逻辑回归评估 1 年死亡率的预测有效性。通过分布和实际属性判断术后最佳 DAOH 时间(30 天或 90 天)。
我们分析了 78921 份记录。30 天 DAOH(DAOH)中位数为 16 天(四分位距[IQR],0-22 天),DAOH 中位数为 75 天(46-82 天)。在存在已知围手术期危险因素的情况下,DAOH 较短。对于在术后 30 天内存活的患者,较短的 DAOH 与更高的 1 年死亡率相关(优势比=0.94;95%可信区间,0.94-0.94)。
DAOH 是急诊剖腹手术后有效的、以患者为中心的结果。我们建议在临床试验、质量保证和质量改进中使用 30 天的 DAOH,因为死亡率严重偏向于 90 天及以后的 DAOH 测量。